Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 2 [364-436]
Ligand
BDBM179474
Substrate
n/a
Meas. Tech.
Biolayer Interferometry (BLI) Binding Assay
pH
7.4000±n/a
Kd
36±8.80 nM
Comments
extracted
Citation
 Wang, S; Ran, X; Zhao, Y; Yang, C; Liu, L; Bai, L; McEachern, D; Stuckey, J; Meagher, JL; Sun, D; Li, X; Zhou, B; Karatas, H; Luo, R; Chinnaiyan, A; Asangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent  US9675697 Publication Date 6/13/2017 
Target
Name:
Bromodomain-containing protein 2 [364-436]
Synonyms:
Bromodomain-containing protein 2 Bromo 2 domain(BRD2 BD2) | Bromodomain-containing protein 2 (BRD2)(BD2) | BRD2_HUMAN | BRD2 | KIAA9001 | RING3
Type:
Protein
Mol. Mass.:
8615.14
Organism:
Human
Description:
BD2 (364-436 aa) of P25440
Residue:
73
Sequence:
KHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVV
  
Inhibitor
Name:
BDBM179474
Synonyms:
US9675697, Cpd. No. 25
Type:
Small organic molecule
Emp. Form.:
n/a
Mol. Mass.:
n/a
SMILES:
COc1cc6c(cc1c2c(C)noc2C)[nH]c5ccnc(c3c(C)[nH]nc3c4ccccc4)c56
Structure:
Search PDB for entries with ligand similarity: